{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT04249232","recordId":"NCT04249232","peptideSlug":"abaloparatide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04249232-abaloparatide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct04249232.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct04249232.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2020-01-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-01-29","publishedAt":"2026-08-23","recordId":"NCT04249232","recordSha256":"937b05c12825d0d93a3ca17a0c34771b0c87e0cf98612f5c3458ce0d5a258c67","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04249232?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2020-07-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-07-28","publishedAt":"2026-08-23","recordId":"NCT04249232","recordSha256":"449ac7bb1831424ca0b37f76fb3eeaf46c7318cf2c97310df7ce202cc9ce4b35","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04249232?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Identification","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2020-09-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-09-17","publishedAt":"2026-08-23","recordId":"NCT04249232","recordSha256":"7ee6443fe2ece4ae8afba92c5893f8dddd701485187d618216204d4c9c6bdcef","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04249232?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2020-11-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2020-11-19","publishedAt":"2026-08-23","recordId":"NCT04249232","recordSha256":"1caf39eed4fb077bc3a0ac2df47e07077a7d30d61a91aac83b28fad409330b20","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04249232?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Sponsor/Collaborators","Study Identification","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2021-03-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2021-03-31","publishedAt":"2026-08-23","recordId":"NCT04249232","recordSha256":"adb7a7b58579420f35f94fcbe680d006ecd9ef24661ab5ca1bef049c5a999804","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04249232?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Sponsor/Collaborators","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2022-03-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2022-03-30","publishedAt":"2026-08-23","recordId":"NCT04249232","recordSha256":"f8fa0dbd55a9665aee06ad72db00bbf49688e0ae67b05cac3d09881d47105fd7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04249232?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2022-07-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2022-07-27","publishedAt":"2026-08-23","recordId":"NCT04249232","recordSha256":"6dca6720d5f80ed0f6ee9e6837d52b29dd5e45d9db6574dff1b991fb524c13a0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04249232?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2023-01-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2023-01-03","publishedAt":"2026-08-23","recordId":"NCT04249232","recordSha256":"2bdaf912d050ef158e6135562057e478ad7909fe78e7c9eb726f056e16ec9c5e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04249232?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2024-02-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"abaloparatide","submittedDate":"2024-02-27","publishedAt":"2026-08-23","recordId":"NCT04249232","recordSha256":"4de70990a89273213cb5ddbea22fd33218c9153d864d6ba13685a0ff9c05f89b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04249232?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2024-06-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"abaloparatide","submittedDate":"2024-06-13","publishedAt":"2026-08-23","recordId":"NCT04249232","recordSha256":"ab05e2b7ef3262d2aae73640c1a0bf750a6ada7cb6c2a7279100664c59f77e7c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT04249232?a=10&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"b71995703d7489ae767ed4296bde6aee15edf7df4f9973dcd7328714207c11ae"}}